Aa
GCMAF Therapy and auto immune diseases
Hi,
I have been reading about the positive impact GCMAF has on immune function on this page especially on hepb, can we now say GCMAF has a positive impact on all immune dysfunction or auto immune diseases?
I have been reading about the positive impact GCMAF has on immune function on this page especially on hepb, can we now say GCMAF has a positive impact on all immune dysfunction or auto immune diseases?
yes it is actually a cure for immune dysfunction which is always present when immune system fails
the easist way is test nagalase, if nagalase is abnormal imme system is blind and not working properly
gcmaf.eu
bgli.nl
this researcher/doctor has examined it also on autism and may other disorders
http://drbradstreet.org/
The first research was published in 1993 and since then many papers have appeared indicating GcMAF cured Cancer and eradicated HIV by simply activating the immune system.
Dr. Nobuto Yamamoto in Philadelphia was the first, but hundreds of scientists have now worked on this and related projects.
How does GcMAF work?
In a healthy person GcMAF instructs macrophages in our bloodstream to scour our bodies and kill malignancies. But malignant cells like cancer send out an enzyme called Nagalase that neutralises the GcMAF; so the macrophages never get the message to go into action – in this way cancer suppresses the immune system, and cancer cells grow unchecked.
To reverse this, we make GcMAF outside the body, and it is injected once a week for 25 weeks for early cancers, 50 or more weeks for late stage cancers. (Encapsulated tumours require additional treatment.) HIV can require as little as 16 weeks.
In its role of immune system regulator, GcMAF reverses other diseases that attack the immune system like Osteoporosis, Aids, Hodgkin’s, Lupus, MS, Fibromyalgia, Parkinson’s, various bacterial and viral infections and various types of Immune dysfunction.
Small pre-clinical trials to build the case are again taking place.
Our GcMAF destroying human cancer cells for 72 hours. At 100ng/ml, panel D, cells show an irregular shape and size. They are significantly smaller as if processes of shrinkage had occurred. Cells appear inhomogeneous and both cytoplasm and nucleus appear irregular as if fragmented. Numerous cellular debris can be observed as well as apoptotic bodies. Clusters are much fewer in number and their borders appear less defined.
Those diagnosed with any of these illnesses, and who have done their own research on it, are invited to respond. We ask for a copy of diagnostic information and update reports from a physician during and after treatments, to help build the case that GcMAF is a cure for various illnesses, which will help to make it available to the public. Participants are free to stop at any time.
What have we learned?
Dr Yamamoto carefully selected his trials: he took fit people with in the early stages of cancer and HIV, and reported 100% success, with no recurrence after many years. He did not attempt to cure people with large tumours.
Our trials are quite different: most people are over 50, some over 70, with advanced or terminal cancers, with significant tumour mass.
We appear to have had stunning results in 20 percent of cases, and we think we have learned enough to take that figure up to 50% in this 2011 round of trials. GcMAF needs normal levels of vitamin D to function strongly, and those participants see significant tumour shrinkage in 8 weeks. But even in low responders, GcMAF appears to stop the advance of cancer.
We have probably proved GcMAF can work for people up to age 67, with terminal stage 4 cancer, and can completely destroy large tumour mass. See "Patients on GcMAF" on the left.
So far those patients who in 8 weeks are cured of symptoms, or whose tumour mass drops significantly, all take exercise, perhaps a 40 minute walk outside each day.
HIV participants who also take the recommended 4000IU of vitamin D daily should expect to see nagalese drop to normal after 16 weeks, and if that doesn't happen we will refund your money.
But the beauty of using your own immune system to cure cancer is that it remembers how to defeat it for the rest of your life: it doesn't come back. And unlike chemotherapy, the side effects are trivial.
Dr. Nobuto Yamamoto in Philadelphia was the first, but hundreds of scientists have now worked on this and related projects.
How does GcMAF work?
In a healthy person GcMAF instructs macrophages in our bloodstream to scour our bodies and kill malignancies. But malignant cells like cancer send out an enzyme called Nagalase that neutralises the GcMAF; so the macrophages never get the message to go into action – in this way cancer suppresses the immune system, and cancer cells grow unchecked.
To reverse this, we make GcMAF outside the body, and it is injected once a week for 25 weeks for early cancers, 50 or more weeks for late stage cancers. (Encapsulated tumours require additional treatment.) HIV can require as little as 16 weeks.
In its role of immune system regulator, GcMAF reverses other diseases that attack the immune system like Osteoporosis, Aids, Hodgkin’s, Lupus, MS, Fibromyalgia, Parkinson’s, various bacterial and viral infections and various types of Immune dysfunction.
Small pre-clinical trials to build the case are again taking place.
Our GcMAF destroying human cancer cells for 72 hours. At 100ng/ml, panel D, cells show an irregular shape and size. They are significantly smaller as if processes of shrinkage had occurred. Cells appear inhomogeneous and both cytoplasm and nucleus appear irregular as if fragmented. Numerous cellular debris can be observed as well as apoptotic bodies. Clusters are much fewer in number and their borders appear less defined.
Those diagnosed with any of these illnesses, and who have done their own research on it, are invited to respond. We ask for a copy of diagnostic information and update reports from a physician during and after treatments, to help build the case that GcMAF is a cure for various illnesses, which will help to make it available to the public. Participants are free to stop at any time.
What have we learned?
Dr Yamamoto carefully selected his trials: he took fit people with in the early stages of cancer and HIV, and reported 100% success, with no recurrence after many years. He did not attempt to cure people with large tumours.
Our trials are quite different: most people are over 50, some over 70, with advanced or terminal cancers, with significant tumour mass.
We appear to have had stunning results in 20 percent of cases, and we think we have learned enough to take that figure up to 50% in this 2011 round of trials. GcMAF needs normal levels of vitamin D to function strongly, and those participants see significant tumour shrinkage in 8 weeks. But even in low responders, GcMAF appears to stop the advance of cancer.
We have probably proved GcMAF can work for people up to age 67, with terminal stage 4 cancer, and can completely destroy large tumour mass. See "Patients on GcMAF" on the left.
So far those patients who in 8 weeks are cured of symptoms, or whose tumour mass drops significantly, all take exercise, perhaps a 40 minute walk outside each day.
HIV participants who also take the recommended 4000IU of vitamin D daily should expect to see nagalese drop to normal after 16 weeks, and if that doesn't happen we will refund your money.
But the beauty of using your own immune system to cure cancer is that it remembers how to defeat it for the rest of your life: it doesn't come back. And unlike chemotherapy, the side effects are trivial.
these are some partecipants in the trials
Participants' progress
Below are the experiences of patients who are using our GcMAF. Participants have access to a forum, and treatment strategy information.
Our aim with this project: To make GcMAF available to the public. It has been used in human studies for 15 years, but no institute has made it available to more than a selected few. We hope to help as many people as possible and to collect their status reports in order to build the case that GcMAF is a cure for immune related diseases, particularly cancer and aids.
Our first trials: May - July 2010
Breast cancer with bone and lung metastasis
Finland: Woman age 67. Initially she had breast cancer for 16 years held at bay with vaccines, then better with LDN , anti-hormone treatment, DCA and other complimentary treatments..
But finally she ended up with metastasies (secondaries) on her ribs, other bones and in her lungs.
She had fluid on her lungs, breathing problems, pain in her bones and was on anti-oestrogen too.
She dropped it all to take just our GcMAF on its own. In 7 weeks she was clear of symptoms, breathing well, her pain gone. She has good energy levels, her whole life back. She will complete the 22-25 week course of GcMAF.
Update after clinical tests 8th July, 10 weeks in: The fluid in the lungs from her lung metastasis has diminished from 1,5 l to 1 l and her cancer marker Ca 15-3 has diminished from 268 to 193 during GcMAF treatment.
Pancreatic cancer with liver metastasis
Sweden: Woman aged 68: She had pancreatic cancer of the neuroendocrine type with liver cancer secondaries. She had pain in her stomach and abdomen so bad she was on morphine. Now, after 7 weeks, she has no symptoms, no pain, gave up the morphine and is a happy active person. She too plans to continue the GcMAF for the full course.
Ovarian and lung cancer
I first contracted cancer in the form of a granulosa cell tumour in 2005. After 2 operations and 3 months of chemo by January 2010 it had reached stage 4 and had spread from my ovaries to my lungs. After that scan in January I was told the chemo had failed, my 5 tumours were still growing, given Tamoxifen hormone, told I had between 3 months and 2 years left to live, and sent on my way.
I started taking Gc MAF at the age of 56 on 16th May 2010; the only feeling or side effect I have from GcMAF is I felt almost from the beginning that I had my old energy back and was feeling much better and fitter in myself. After 8 weeks of taking only GcMAF and Tamoxifen I went for a scan. This showed all tumours had shrunk, the four in my lungs were now hardly noticeable and that the aggressive tumour in my pelvis had shrunk from 7.4cm to 4.1 cm. This is a significant decrease in size.
The stand-in consultant was very excited, and said these were excellent results. As I did not know her, and she did not ask, I did not tell her why.
On the 21st Oct I had another scan; the improvements continued; the secondaries appeared to be merely scar tissue, and the pelvic tumour had shrunk to 3.5 cm
In the winter my improvements seemed much slower; we now know because GcMAF needs normal vitamin D levels. But I've just got back from a wild month in Australia and Thailand, the sunshine should have done wonders for my vitamin D levels, and for my next scan in April.
I will keep you updated. But I am over the moon and feel better than ever. And yes, you can phone me if you like.
Gail in London. (The only one to be continuously on our GcMAF)
We had to set up a new facility with much higher capacity, and were not in production from July 2010 to December.
Aids
40 year old Italian woman with symptoms which severely degraded her life. After ten shots of our GcMAF ending in October 2010 her CD4 climbed from 50 to 300, her symptoms disappeared, then she went on holiday and stopped the GcMAF. She's now classified as HIV. Published by Prof Ruggiero's team 29th March, see bottom of "Tests of our GcMAF".
Second Trials: 1st January 2011 onwards - May is too early for most results.
25 new participants started in January 2011, including 8 HIV and one Parkinson's.
Immune related chronic sinus condition
Man, 50, USA. 10 years of consultations and medicines did not improve his condition. He began taking our GcMAF on 1st January 2011. "The first few weeks, while taking GcMAF, I noticed a great change in my physical well being. I was energized and my sinus' began to clear. They have not been as clear for this amount of time for years! Then things started to slow down. I feel like things are continuing to get better just at a slower pace than the first two to three weeks. Since it takes many weeks for cancer and such to be eradicated, I figure it will take many weeks to completely get rid of my symptoms as well. Yes, I'll take the vitamin D as well.
11th Feb 2011. If you look at the area around my nose in the before photo it is all swollen. I could not breath through my nose at all and had constant sinus drainage. In the after photo the swollen area around my nose is GONE completely and I am able to get air flow through my nose. I have not been able to get air flow through my nose for almost 15 years! Now I can!
Breast cancer
Rose, California: After my first vial of GcMAF my mastectomy pathology report came back clean, good margins and clear lymph nodes. A 1.5cm soft cancer had completely disappeared.
Prostate
Bernard, Norway. Prostate cancer with bone secondaries. Walking again after 3 months of GcMAF, his PSA reading down from 120 to 60.
Myeloma
Man, Austria, Parkinsons too, cured of Myeloma in 10 weeks.
HIV - four apparent aids/HIV cures, but most haven't been on it long enough.
Austria, two women in their 40s. Both now symptom free, their lives back to normal in 10 shots.
Stuart, 53, outside Europe, his life returning to normal after 8 shots. We will have full blood test results on 8 participants early June.
Fibromyalgia
Michel, Spain: I stole some of my wife's GcMAF for my five year long chronic back inflammation. At the end of two weeks it was gone! I'm feeling a bit guilty now - may I please have another vial?
We can put you in touch with our participants.
http://www.gcmaf.eu/info/index.php?option=com_content&view=category&layout=blog&id=6&Itemid=2
some GCMAF research
the response to gcmaf is correlated on vdr receptors, even if there is some response on any receptor type otherwise immune system wouldn t work on about 25% people
in vitro:
“bb/FF” genotype highest response, 25% of italina population
“Bb/Ff” genotype medium response, 50% of italian population
“BB/ff” homozygous no response, 25% of italian population.high riske of Osteoporosis, arthritis
some GCMAF research
the response to gcmaf is correlated on vdr receptors, even if there is some response on any receptor type otherwise immune system wouldn t work on about 25% people
in vitro:
“bb/FF” genotype highest response, 25% of italina population
“Bb/Ff” genotype medium response, 50% of italian population
“BB/ff” homozygous no response, 25% of italian population.high riske of Osteoporosis, arthritis
¿Donde comprais el GcMAF?
Where do you by GcMAF?
¿Existe algún sitio en España o Francia donde hagan el test de Nagalase?
Is there some laboratory in Spain or France where to have a Nagalase test being done?
Helios
Where do you by GcMAF?
¿Existe algún sitio en España o Francia donde hagan el test de Nagalase?
Is there some laboratory in Spain or France where to have a Nagalase test being done?
Helios
no there are only research labs doing this test worldwide
there are only two labs, who tests nagalase for the patients on studies and to private:
europeanlaboratory.nl
redlabs.com
there are others in germany but doctors studying gcmaf know them, i dont know
Have an Answer?
You are reading content posted in the Hepatitis B Community
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
